Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma

Published:2009-04-24 Issue:1 Volume:34 Page:83-87
ISSN:0036-553X
Container-title:Scandinavian Journal of Haematology
language:en
Short-container-title:

Author:

Willemze R.,Peters W. G.,Hennik M. B.,Fibbe W. E.,Kootte A. M. M.,Berkel M.,Lie R.,Rodenburg C. J.,Veltkamp J. J.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1985.tb00748.x/fullpdf

Reference19 articles.

1. High dose cytosine arabinoside in the treatment of patients with refractory acute non-lymphocytic leukaemia;Karanes;Blood,1979

2. Successful treatment of patients (pts) with refractory acute nonlympocytic leukemia (ANLL) using high dose cytosine arabinoside (HDAraC) with and without anthra-cycline;Herzig;Blood,1981

3. High dose cytosine arabinoside (Ara-C) and m-AMSA in refractory acute non-lymphocytic leukemia (ANLL);Hines;Blood,1981

4. Treatment of refractory acute leukaemia with high dose cytosine arabinoside;Willemze;Br J Haematol,1982

5. High dose cytosine arabinoside in the management of refractory acute leukaemia;Willemze;Scand J Haematol,1982

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition;BMC Bioinformatics;2019-03

2. Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study;Blood Cancer Journal;2016-12

3. Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside;European Journal of Haematology;2009-04-24

4. Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias*;European Journal of Haematology;2009-04-24

5. RESULTS OF INDUCTION AND CONSOLIDATION TREATMENT WITH INTERMEDIATE AND HIGH-DOSE ARA-C AND m-AMSA CONTAINING REGIMENS IN PATIENTS WITH PRIMARILY FAILED OR RELAPSED ACUTE LEUKEMIA AND NON-HODGKIN'S LYMPHOMA;Scandinavian Journal of Haematology;2009-04-24